WORLD’S LEADING PRODUCTS FOR VIETNAMESE HEALTH

See more

HOANG YEN MEDITECH

WORLD’S LEADING PRODUCTS FOR VIETNAMESE HEALTH

Hoang Yen Meditech Vietnam Co., Ltd. is a medical products distributor specializing in providing the world’s leading health care technologies to Vietnamese people.

CORE VALUES

OUR STRENGTHS

Hoang Yen Meditech Vietnam is a combination of a new and dynamic team of employees, led by experienced leaders in the healthcare field. The company promises to expand its business activities in the coming years, while developing the quality of products, services, and human resources.

YOUNG AND CREATIVE

With a young and innovative team, Hoang Yen will continuously develop and adapt to the market.

STRONG CONNECTION

Hoang Yen has strong connections both internally and with external partners and customers.

FOCUS ON CLIENT’S NEED

Prioritizing customer needs to provide excellent and accurate services.

NON-STOP LEARNING

Always keeping up with the development of new technologies to have the most accurate view of the market.

IMPORTANT MILESTONES

2017

Establishment of Hoang Yen Meditech Viet Nam Co., Ltd.

2018

Thrive in the field of distribution medical consumables and pharmacy. Became reseller of Dräger, Maquet, Getinge.

2019

Implementing various projects of distribution Medical Ventilators, Anesthesia Machine, Ultrasound, Laboratory Equipment for large hospital in major cities. Becoming a distributor of ACS Inc. for Cyclon Generator System.

2020

Providing medical supplies for the prevention of Covid-19 pandemic. Expanding business areas into Advanced Therapy field.

2021

Expanding business areas into Diagnostic Imaging and maintain developing progress, implementing projects to provide medical equipment for hospitals in the fight against Covid-19 pandemic. Becoming the authorized distributor of Boston Scientific Corporation

2022

Continue to develop in the domain of Cardiology, create strong relation with the customers. Signed OEM contract with B&S Corporation about Post Biotics Supplements.

2023

Promote development in the field of cardiovascular disease, develop the pharmaceutical market.